Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Cash & Equivalents (2021 - 2023)

Historic Cash & Equivalents for Zymeworks (ZYME) over the last 3 years, with Q3 2023 value amounting to $94.3 million.

  • Zymeworks' Cash & Equivalents fell 182.14% to $94.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $94.3 million, marking a year-over-year decrease of 182.14%. This contributed to the annual value of $400.9 million for FY2022, which is 9860.2% up from last year.
  • As of Q3 2023, Zymeworks' Cash & Equivalents stood at $94.3 million, which was down 182.14% from $142.1 million recorded in Q2 2023.
  • In the past 5 years, Zymeworks' Cash & Equivalents ranged from a high of $400.9 million in Q4 2022 and a low of $94.3 million during Q3 2023
  • Over the past 3 years, Zymeworks' median Cash & Equivalents value was $161.8 million (recorded in 2023), while the average stood at $186.1 million.
  • Per our database at Business Quant, Zymeworks' Cash & Equivalents skyrocketed by 9860.2% in 2022 and then crashed by 182.14% in 2023.
  • Over the past 3 years, Zymeworks' Cash & Equivalents (Quarter) stood at $201.9 million in 2021, then surged by 98.6% to $400.9 million in 2022, then crashed by 76.47% to $94.3 million in 2023.
  • Its Cash & Equivalents was $94.3 million in Q3 2023, compared to $142.1 million in Q2 2023 and $181.6 million in Q1 2023.